A detailed history of Mjt & Associates Financial Advisory Group, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Mjt & Associates Financial Advisory Group, Inc. holds 54 shares of INCY stock, worth $5,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Holding current value
$5,722
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$67.27 - $86.96 $3,632 - $4,695
54 New
54 $4.58 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mjt & Associates Financial Advisory Group, Inc. Portfolio

Follow Mjt & Associates Financial Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjt & Associates Financial Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mjt & Associates Financial Advisory Group, Inc. with notifications on news.